A hypertensive patient with BP 160/90 mm of Hg presents with increased level of Lipoprotein a. Which Hypolipidemic drug will you prescribe?
**Core Concept**
The patient has hypertension and elevated levels of Lipoprotein(a), a risk factor for cardiovascular disease. **Lipoprotein(a)** is a type of low-density lipoprotein that is associated with increased risk of atherosclerotic cardiovascular disease. Managing **hyperlipidemia** is crucial in this patient.
**Why the Correct Answer is Right**
Since the correct answer is not provided, let's discuss the general approach to managing elevated Lipoprotein(a) levels. **Niacin** is often considered for patients with high Lipoprotein(a) levels, as it can effectively lower these levels. However, without the correct answer, we cannot specify the exact mechanism or choice.
**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option, it's challenging to provide a detailed explanation.
**Option B:** Similarly, without the option, we cannot discuss its inaccuracy.
**Option C:** This option's incorrectness depends on its content, which is not provided.
**Option D:** The same applies to this option, lacking specific details to address.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that **Lipoprotein(a)** management often involves **niacin**, given its efficacy in reducing these levels. However, the choice of hypolipidemic drug should be tailored to the individual patient's lipid profile and other risk factors.
**Correct Answer:** Not provided in the query.